RHÖN-KLINIKUM Aktiengesellschaft: Changes on the Board of Management
RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Personnel
Bad Neustadt a. d. Saale, 18 October 2022
RHÖN-KLINIKUM AG: Changes on the Board of Management
The Chief Executive Officer of RHÖN-KLINIKUM AG, Dr. Christian Höftberger, asked the Chairman of the Supervisory Board of the company last week to terminate his contract ahead of schedule. Consequently, the Supervisory Board resolved today, in a meeting convened at short notice, to comply with this request. With this consensual step, both Dr. Christian Höftberger and the Supervisory Board would like to create room for new dynamics in the stalled negotiations between RHÖN-KLINIKUM AG and the State of Hesse on securing the future of the University Hospital Gießen and Marburg (UKGM) in the interests of the employees and all patients of UKGM.
As the new Chief Executive Officer of RHÖN-KLINIKUM AG, the Supervisory Board has appointed Prof. Dr. Tobias Kaltenbach, who will take office on 1 November 2022. In addition, the Supervisory Board has decided to reduce the size of the company's Board of Management to three members. Prof. Dr. Bernd Griewing will move in his function as CMO (Chief Medical Officer) to the position of a General Representative. As of 1 November 2022, the Board of Management will thus consist of Prof. Dr. Tobias Kaltenbach (CEO), Dr. Stefan Stranz (CFO) and Dr. Gunther K. Weiß (COO).
T. +49 9771 65-12250 | email@example.com
RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale
18-Oct-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Salzburger Leite 1|
|97616 Bad Neustadt a.d.Saale|
|Phone:||+49 (0)9771 - 65-0|
|Fax:||+49 (0)9771 - 97 467|
|Listed:||Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange|
|EQS News ID:||1466081|
|End of Announcement||EQS News Service|